cordbloodsymposium

Presentations(27)

A Potential Global Role for Dipeptidylpeptidase 4 (DPP4/CD26) and Its Inhibition In the Regulation of Hematopoiesis and Other Cell Systems

Cord Blood Natural Killer Cells for Immunotherapy

Multicenter Study of Third-Party Virus-Specific T cells to Treat Adenovirus, Epstein-Barr Virus or Cytomegalovirus Infections after Hematopoietic Stem Cell Transplantation

Autoimmune Complications After Cord Blood Transplantation

Graft-vs.-Host Disease and Umbilical Cord Transplantation

Expenses as an Issue Inhibiting the Use of Cord Blood Transplantation

Alterative Donor HSCT

Outcomes Using Single and Double Unit Cord Blood Transplant Grafts

Myeloablative Umbilical Cord Blood Transplantation for Hematologic Malignancies is Comparable to Unrelated Donor Transplantation: a Retrospective Single Center Study

Challenges in Performing Umbilical Cord Blood Transplants in Developing Countries

A Potential Global Role for Dipeptidylpeptidase 4 (DPP4/CD26) and Its Inhibition In The Regulation of Hematopoiesis and Other Cell Systems

Haplo-cord transplantation offers similar results compared to MUD transplantation in High-Risk Adult Patients with Hematologic Disorders

Outcomes of Double Unit Cord Blood Transplantation in Patients with Malignant Disorders: Eurocord Registry Analysis

Double Unit Cord Blood Transplantation for Acute Leukemia

The Significance of the Direction of the HLA Mismatch in Cord Blood Matching and the Implication of Graft-Specific Anti-HLA Antibodies

Anti-HLA Antibodies and Outcomes after Cord Blood Transplantation

Unrelated Cord Blood Transplantation In Adults with Hematological Malignancies Eurocord Results

Cord Blood Transplantation: Are the indications changing?